newmont corp. - NEM
NEM
Close Chg Chg %
48.39 -0.31 -0.64%
Closed Market
48.08
-0.31 (0.64%)
Volume: 11.26M
Last Updated:
Mar 28, 2025, 3:59 PM EDT
Company Overview: newmont corp. - NEM
NEM Key Data
Open $48.85 | Day Range 47.99 - 49.52 |
52 Week Range 36.10 - 58.72 | Market Cap $54.55B |
Shares Outstanding 1.13B | Public Float 1.13B |
Beta 0.56 | Rev. Per Employee N/A |
P/E Ratio 16.59 | EPS $2.93 |
Yield 211.02% | Dividend $0.25 |
EX-DIVIDEND DATE Mar 4, 2025 | SHORT INTEREST N/A |
AVERAGE VOLUME 10.81M |
NEM Performance
1 Week | 1.52% | ||
1 Month | 12.23% | ||
3 Months | 27.06% | ||
1 Year | 34.15% | ||
5 Years | 3.73% |
NEM Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
24
Full Ratings ➔
About newmont corp. - NEM
Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.
NEM At a Glance
Newmont Corp.
6900 East Layton Avenue
Denver, Colorado 80237
Phone | 1-303-863-7414 | Revenue | 18.56B | |
Industry | Precious Metals | Net Income | 3.28B | |
Sector | Non-Energy Minerals | 2024 Sales Growth | 57.597% | |
Fiscal Year-end | 12 / 2025 | Employees | 42,600 | |
View SEC Filings |
NEM Valuation
P/E Current | 16.587 |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | 13.027 |
Price to Sales Ratio | 2.303 |
Price to Book Ratio | 1.402 |
Price to Cash Flow Ratio | 6.715 |
Enterprise Value to EBITDA | 5.589 |
Enterprise Value to Sales | 2.606 |
Total Debt to Enterprise Value | 0.188 |
NEM Efficiency
Revenue/Employee | 435,610.329 |
Income Per Employee | 76,995.305 |
Receivables Turnover | 17.573 |
Total Asset Turnover | 0.332 |
NEM Liquidity
Current Ratio | 1.627 |
Quick Ratio | 1.338 |
Cash Ratio | 0.483 |
NEM Profitability
Gross Margin | 34.618 |
Operating Margin | 30.975 |
Pretax Margin | 24.665 |
Net Margin | 17.675 |
Return on Assets | 5.865 |
Return on Equity | 11.127 |
Return on Total Capital | 8.406 |
Return on Invested Capital | 8.807 |
NEM Capital Structure
Total Debt to Total Equity | 30.376 |
Total Debt to Total Capital | 23.299 |
Total Debt to Total Assets | 16.133 |
Long-Term Debt to Equity | 26.864 |
Long-Term Debt to Total Capital | 20.605 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Newmont Corp. - NEM
Collapse All in section
All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
---|---|---|---|---|---|
Sales/Revenue
| 12.19B | 11.95B | 11.78B | 18.56B | |
Sales Growth
| +6.77% | -1.98% | -1.46% | +57.60% | |
Cost of Goods Sold (COGS) incl D&A
| 9.81B | 9.80B | 10.61B | 12.13B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 4.17B | 3.11B | 3.64B | 2.90B | |
Depreciation
| - | - | - | - | - |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| +24.72% | -0.09% | +8.16% | +14.41% | |
Gross Income
| 2.38B | 2.14B | 1.17B | 6.42B | |
Gross Income Growth
| -33.03% | -9.76% | -45.43% | +449.06% | |
Gross Profit Margin
| +19.49% | +17.94% | +9.94% | +34.62% |
2021 | 2022 | 2023 | 2024 | 5-year trend | |
---|---|---|---|---|---|
SG&A Expense
| 413.00M | 505.00M | 499.00M | 639.00M | |
Research & Development
| 154.00M | 229.00M | 200.00M | 197.00M | |
Other SG&A
| 259.00M | 276.00M | 299.00M | 442.00M | |
SGA Growth
| +5.63% | +22.28% | -1.19% | +28.06% | |
Other Operating Expense
| 47.00M | 18.00M | 21.00M | 37.00M | |
Unusual Expense
| 236.00M | 1.46B | 2.36B | 1.00M | |
EBIT after Unusual Expense
| 1.68B | 157.00M | (1.71B) | 5.75B | |
Non Operating Income/Expense
| (306.00M) | 19.00M | (73.00M) | (785.00M) | |
Non-Operating Interest Income
| 18.00M | 78.00M | 148.00M | 152.00M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 266.00M | 227.00M | 248.00M | 385.00M | |
Interest Expense Growth
| -8.59% | -14.66% | +9.25% | +55.24% | |
Gross Interest Expense
| 304.00M | 296.00M | 337.00M | 499.00M | |
Interest Capitalized
| 38.00M | 69.00M | 89.00M | 114.00M | |
Pretax Income
| 1.11B | (51.00M) | (2.03B) | 4.58B | |
Pretax Income Growth
| -64.75% | -104.60% | -3,882.35% | +325.36% | |
Pretax Margin
| +9.09% | -0.43% | -17.25% | +24.66% | |
Income Tax
| 1.10B | 455.00M | 526.00M | 1.40B | |
Income Tax - Current - Domestic
| 71.00M | 47.00M | 20.00M | 93.00M | |
Income Tax - Current - Foreign
| 1.14B | 686.00M | 610.00M | 1.22B | |
Income Tax - Deferred - Domestic
| (5.00M) | (236.00M) | (62.00M) | 157.00M | |
Income Tax - Deferred - Foreign
| (104.00M) | (42.00M) | (42.00M) | (77.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 176.00M | (399.00M) | (2.49B) | 3.31B | |
Minority Interest Expense
| (933.00M) | 60.00M | 27.00M | 33.00M | |
Net Income
| 1.11B | (459.00M) | (2.52B) | 3.28B | |
Net Income Growth
| -58.40% | -141.39% | -449.24% | +230.11% | |
Net Margin Growth
| +9.10% | -3.84% | -21.41% | +17.68% | |
Extraordinaries & Discontinued Operations
| - | - | - | 57.00M | - |
Discontinued Operations
| - | - | - | 57.00M | - |
Net Income After Extraordinaries
| 1.17B | (459.00M) | (2.52B) | 3.28B | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 1.17B | (459.00M) | (2.52B) | 3.28B | |
EPS (Basic)
| 1.4593 | -0.5781 | -2.9976 | 2.8621 | |
EPS (Basic) Growth
| -58.53% | -139.61% | -418.53% | +195.48% | |
Basic Shares Outstanding
| 799.00M | 794.00M | 841.00M | 1.15B | |
EPS (Diluted)
| 1.4557 | -0.5781 | -2.9976 | 2.8571 | |
EPS (Diluted) Growth
| -58.53% | -139.71% | -418.53% | +195.31% | |
Diluted Shares Outstanding
| 801.00M | 795.00M | 841.00M | 1.15B | |
EBITDA
| 6.08B | 4.73B | 4.29B | 8.65B | |
EBITDA Growth
| +8.08% | -22.32% | -9.22% | +101.63% | |
EBITDA Margin
| +49.92% | +39.56% | +36.44% | +46.62% |
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 52.754 | |
Number of Ratings | 24 | Current Quarters Estimate | 0.851 | |
FY Report Date | 03 / 2025 | Current Year's Estimate | 3.464 | |
Last Quarter’s Earnings | 1.40 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 3.48 | Next Fiscal Year Estimate | 3.688 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 11 | 11 | 19 | 17 |
Mean Estimate | 0.85 | 0.82 | 3.46 | 3.69 |
High Estimates | 1.04 | 1.06 | 4.60 | 5.10 |
Low Estimate | 0.53 | 0.55 | 2.34 | 2.58 |
Coefficient of Variance | 20.02 | 16.69 | 15.99 | 19.32 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 12 | 11 | 11 |
OVERWEIGHT | 3 | 2 | 3 |
HOLD | 9 | 10 | 9 |
UNDERWEIGHT | 0 | 1 | 2 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Newmont Corp. - NEM
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Newmont Corp. - NEM
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Mar 6, 2025 | Bruce Robert Brook Director | 47,916 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $43.71 per share | 2,094,408.36 |
Mar 6, 2025 | Peter Ivan Toth EVP, Chief Sustain & Dev Off | 86,526 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $43.71 per share | 3,782,051.46 |
Mar 6, 2025 | Natascha Viljoen EVP & COO | 148,244 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $43.71 per share | 6,479,745.24 |
Mar 3, 2025 | Francois Hardy EVP & CTO | 40,931 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $42.93 per share | 1,757,167.83 |
Mar 3, 2025 | Jennifer Cmil EVP and Chief People Officer | 76,187 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $42.93 per share | 3,270,707.91 |
Mar 3, 2025 | Thomas Palmer President & CEO; Director | 300,555 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $42.93 per share | 12,902,826.15 |
Mar 3, 2025 | Karyn F. Ovelmen EVP & CFO | 74,677 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $42.93 per share | 3,205,883.61 |
Mar 3, 2025 | Brian C. Tabolt SVP & CAO | 41,454 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $42.93 per share | 1,779,620.22 |
Feb 27, 2025 | Peter Wexler EVP & Chief Legal Officer | 83,468 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Jul 4, 2024 | Harry Milton Conger Director | 3,552 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 3, 2024 | Peter Wexler Chief Legal Officer | 71,358 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Sally Anne Layman Director | 6,512 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Gregory H. Boyce Director | 41,657 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Emma FitzGerald Director | 11,768 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Jose Manuel Madero Garza Director | 13,312 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Jane Musser Nelson Director | 54,147 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Julio Manuel Quintana Director | 41,657 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Susan N. Story Director | 14,848 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Philip Stanley Aiken Director | 14,488 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | René Médori Director | 24,504 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |